Health Outlook Therapeutics Announces Full Cash Pre-Payment of Convertible Promissory Note July 5, 2022
ESG UGE Announces Private Placement of up to $3 Million of Project Development Green Bonds July 5, 2022
Health Fulcrum Therapeutics Enrolls First Patient in Pivotal Global Phase 3 Clinical Trial of Losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD) July 5, 2022
ESG Questor Technology Inc. Announces Grant of Share Based Awards, Changes in Board Composition and Bank Facilities July 5, 2022
Search
pr
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
July 5, 2022
